Skip to content

BOSTON SCIENTIFIC CORP

BSX · XNYS

CIK 885725fmd_1AC21JF054KRBHN1B3G4NVJS6BManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods

Latest annual · FY2025

Millions
Total revenues
20,074
Gross profit
13,854
Operating income
3,613
Net income
2,892
Free cash flow
3,658

Latest quarter · Q3 FY2026

Millions
Total revenues
5,138
Gross profit
3,428
Operating income
828
Net income
580
Free cash flow
868

Daily close · BSXIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

45.15 USD

406080100120Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+16.5%
Revenue, 5 yearsFY2020 to FY2025
+15.2%
Net income, 5 yearsFY2020 to FY2025
n/m

BOSTON SCIENTIFIC CORP (BSX) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$20.1 billion$16.7 billion+19.9%10-K 2026-02-17 · proof
Gross profit$13.9 billion$11.5 billion+20.6%10-K 2026-02-17 · proof
Operating income$3.6 billion$2.6 billion+38.8%10-K 2026-02-17 · proof
Net income$2.9 billion$1.8 billion+56.7%10-K 2026-02-17 · proof
Cash from operating activities$4.5 billion$3.4 billion+32%10-K 2026-02-17 · proof
Free cash flow$3.7 billion$2.6 billion+38.3%10-K 2026-02-17 · proof
Total assets$43.7 billion$39.4 billion+10.9%10-K 2026-02-17 · proof
Total liabilities$19.2 billion$17.4 billion+10.4%10-K 2026-02-17 · proof
Cash and cash equivalents$2 billion$414 million+374.6%10-K 2026-02-17 · proof
Total debt$11.4 billion$10.7 billion+6.4%10-K 2026-02-17 · proof
What was BOSTON SCIENTIFIC CORP (BSX)'s revenue in fiscal 2025?
BOSTON SCIENTIFIC CORP (BSX) reported revenue of $20.1 billion for fiscal 2025 (the year ended Dec 31, 2025), against $16.7 billion the year before (+19.9%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What was BOSTON SCIENTIFIC CORP (BSX)'s gross profit in fiscal 2025?
BOSTON SCIENTIFIC CORP (BSX) reported gross profit of $13.9 billion for fiscal 2025 (the year ended Dec 31, 2025), against $11.5 billion the year before (+20.6%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What was BOSTON SCIENTIFIC CORP (BSX)'s operating income in fiscal 2025?
BOSTON SCIENTIFIC CORP (BSX) reported operating income of $3.6 billion for fiscal 2025 (the year ended Dec 31, 2025), against $2.6 billion the year before (+38.8%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What was BOSTON SCIENTIFIC CORP (BSX)'s net income in fiscal 2025?
BOSTON SCIENTIFIC CORP (BSX) reported net income of $2.9 billion for fiscal 2025 (the year ended Dec 31, 2025), against $1.8 billion the year before (+56.7%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What was BOSTON SCIENTIFIC CORP (BSX)'s cash from operating activities in fiscal 2025?
BOSTON SCIENTIFIC CORP (BSX) reported cash from operating activities of $4.5 billion for fiscal 2025 (the year ended Dec 31, 2025), against $3.4 billion the year before (+32%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What was BOSTON SCIENTIFIC CORP (BSX)'s free cash flow in fiscal 2025?
BOSTON SCIENTIFIC CORP (BSX) reported free cash flow of $3.7 billion for fiscal 2025 (the year ended Dec 31, 2025), against $2.6 billion the year before (+38.3%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What are BOSTON SCIENTIFIC CORP (BSX)'s total assets?
As of Dec 31, 2025, BOSTON SCIENTIFIC CORP (BSX) reported total assets of $43.7 billion, against $39.4 billion a year earlier (+10.9%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What are BOSTON SCIENTIFIC CORP (BSX)'s total liabilities?
As of Dec 31, 2025, BOSTON SCIENTIFIC CORP (BSX) reported total liabilities of $19.2 billion, against $17.4 billion a year earlier (+10.4%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What are BOSTON SCIENTIFIC CORP (BSX)'s cash and cash equivalents?
As of Dec 31, 2025, BOSTON SCIENTIFIC CORP (BSX) reported cash and cash equivalents of $2 billion, against $414 million a year earlier (+374.6%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC
What is BOSTON SCIENTIFIC CORP (BSX)'s total debt?
As of Dec 31, 2025, BOSTON SCIENTIFIC CORP (BSX) reported total debt of $11.4 billion, against $10.7 billion a year earlier (+6.4%). Source: the 10-K filed with the SEC on Feb 17, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BSX&period_type=annual&limit=5"

Information only, not investment advice.

BSX · FinancialMD